Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Enzalutamide-Resistant Progression of Castration-Resistant Prostate Cancer Is Driven via the JAK2/STAT1-Dependent Pathway
Yong Luo, Xiaobing Yang, Spyridon P. Basourakos, et al.
Frontiers in Molecular Biosciences (2021) Vol. 8
Open Access | Times Cited: 10

Showing 10 citing articles:

Ectopic JAK–STAT activation enables the transition to a stem-like and multilineage state conferring AR-targeted therapy resistance
Su Deng, Choushi Wang, Yunguan Wang, et al.
Nature Cancer (2022) Vol. 3, Iss. 9, pp. 1071-1087
Open Access | Times Cited: 87
Integrated single-cell analysis defines the epigenetic basis of castration-resistant prostate luminal cells
Jason Kirk, Jie Wang, Mark D. Long, et al.
Cell stem cell (2024) Vol. 31, Iss. 8, pp. 1203-1221.e7
Open Access | Times Cited: 5
Omics Investigations of Prostate Cancer Cells Exposed to Simulated Microgravity Conditions
Herbert Schulz, Fatima Abdelfattah, Anna Heinrich, et al.
Biomolecules (2025) Vol. 15, Iss. 2, pp. 303-303
Open Access
Chemokine receptor CXCR7 activates Aurora Kinase A and promotes neuroendocrine prostate cancer growth
Galina Gritsina, Ka-wing Fong, Xiaodong Lü, et al.
Journal of Clinical Investigation (2023) Vol. 133, Iss. 15
Open Access | Times Cited: 9
Targeting Protein Kinases and Epigenetic Control as Combinatorial Therapy Options for Advanced Prostate Cancer Treatment
Soghra Bagheri, Mahdie Rahban, Fatemeh Bostanian, et al.
Pharmaceutics (2022) Vol. 14, Iss. 3, pp. 515-515
Open Access | Times Cited: 12
Potential Application of Leelamine as a Novel Regulator of Chemokine-Induced Epithelial-to-Mesenchymal Transition in Breast Cancer Cells
Young Yun Jung, Jae‐Young Um, Gautam Sethi, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 17, pp. 9848-9848
Open Access | Times Cited: 10
Intratumoral immune heterogeneity of prostate cancer characterized by typing and hub genes
Jianpeng Han, Yan Zhou, Chun‐Dong Zhang, et al.
Journal of Cellular and Molecular Medicine (2022) Vol. 27, Iss. 1, pp. 101-112
Open Access | Times Cited: 8
Beyond Expression: Role of Phosphorylated Residues of EZH2 in Lineage Plasticity in Prostate Cancer
Shaghayegh Nouruzi, Nakisa Tabrizian, Amina Zoubeidi
Endocrinology (2023) Vol. 164, Iss. 4
Open Access | Times Cited: 2
Associations of CYLD, JAK2 and TLR4 Genotypes with PSA Levels and Immunophenotype in Benign Prostatic Hyperplasia and Prostate Cancer
Le Vu Duy, Phạm Thị Mai Hương, Nguyễn Trung Nam, et al.
Frontiers in Bioscience-Landmark (2024) Vol. 29, Iss. 7
Open Access
Genetic evidence supporting a causal role of Janus kinase 2 in prostate cancer: a Mendelian randomization study
Yujia Xi, Rui Wen, Ran Zhang, et al.
The Aging Male (2023) Vol. 26, Iss. 1
Open Access
Page 1

Scroll to top